In this study, we did not only show that PMP22 gene expression has prognostic value on DFS and OS, we also showed that PMP22 gene expression is as powerful as nodal status and ER status to predict mortality of breast cancer patients by calculating the proportion of explained variation. This evidence concerns the gene PMP22 and breast carcinoma.